Allergic Bronchopulmonary Aspergillosis
Symptoms, Doctors, Treatments, Advances & More

Save information for later
Sign Up

Learn About Allergic Bronchopulmonary Aspergillosis

What is the definition of Allergic Bronchopulmonary Aspergillosis?
Allergic bronchopulmonary aspergillosis is an allergic lung reaction to a type of fungus (Aspergillus fumigatus). Symptoms vary, but may include wheezing, bronchial hyperreactivity, hemoptysis, productive cough, low-grade fever, malaise, and weight loss. It is more common in people who have asthma or cystic fibrosis. The clinical course of Allergic bronchopulmonary aspergillosis is variable.
What are the alternative names for Allergic Bronchopulmonary Aspergillosis?
  • Allergic bronchopulmonary aspergillosis
  • ABPA
  • Allergic bronchopulmonary mycosis
  • Aspergillosis, allergic bronchopulmonary
  • Hinson-Pepys disease
Who are the top Allergic Bronchopulmonary Aspergillosis Local Doctors?
Elite in Allergic Bronchopulmonary Aspergillosis
Elite in Allergic Bronchopulmonary Aspergillosis
Referral may be required
Tokai, JP 

Tsuyoshi Oguma practices practicing medicine in Tokai, Japan. Mr. Oguma is rated as an Elite expert by MediFind in the treatment of Allergic Bronchopulmonary Aspergillosis. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Allergic Bronchopulmonary Aspergillosis, Aspergillosis, Asthma, Lung Transplant, and Liver Embolization.

Elite in Allergic Bronchopulmonary Aspergillosis
Allergy and Immunology
Elite in Allergic Bronchopulmonary Aspergillosis
Allergy and Immunology
Referral required

Emory Clinic - Pulmonology At Executive Park

1605 Chantilly Drive Northeast, Ste301, 
Atlanta, GA 
Languages Spoken:
English, Korean
Accepting New Patients
Offers Telehealth

Frances Lee is an Allergy and Immunologist practicing medicine in Atlanta, Georgia. Dr. Lee is rated as an Elite provider by MediFind in the treatment of Allergic Bronchopulmonary Aspergillosis. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Allergic Bronchopulmonary Aspergillosis, Aspergillosis, Asthma, and Pulmonary Aspergilloma. Dr. Lee is board certified in American Board Of Internal Medicine, 2000. Dr. Lee is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Allergic Bronchopulmonary Aspergillosis
Elite in Allergic Bronchopulmonary Aspergillosis
Referral may be required

DM Wayanad Institute Of Medical Sciences

Wayanad, KL, IN 

Ritesh Agarwal practices practicing medicine in Wayanad, India. Mr. Agarwal is rated as an Elite expert by MediFind in the treatment of Allergic Bronchopulmonary Aspergillosis. He is also highly rated in 36 other conditions, according to our data. His clinical expertise encompasses Allergic Bronchopulmonary Aspergillosis, Aspergillosis, Sarcoidosis, Endoscopy, and Lung Transplant.

What are the latest Allergic Bronchopulmonary Aspergillosis Clinical Trials?
A Randomized Controlled Trial to Compare Oral Itraconazole and Standard Care Versus Standard Care Alone in Patients With Non-cystic Fibrosis Related Bronchiectasis With Chronic Aspergillus Infection in Reducing Bronchiectasis Exacerbations

Summary: There is an intricate link between bronchiectasis and fungi. Patients with cystic fibrosis frequently manifest fungal sensitization and fungal colonization with Aspergillus fumigatus.6 Aspergillus species also has a cause-and-effect relationship with non-CF (cystic fibrosis) bronchiectasis.7, 8 In allergic bronchopulmonary aspergillosis (ABPA), Aspergillus is the cause of bronchiectasis. In contra...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Machine Learning-Based Prediction of Recurrence Risk in Allergic Bronchopulmonary Aspergillosis and Its Clinical Decision-Making Value: A Multicenter Study With External Validation

Summary: This multicenter bidirectional cohort study aims to develop and externally validate a machine learning model for predicting the risk of acute exacerbation within 1 year in patients with allergic bronchopulmonary aspergillosis (ABPA) during the stable phase, and further to evaluate the model's practical value in risk stratification and clinical decision-making. All patients diagnosed with ABPA acco...

Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center

What are the Latest Advances for Allergic Bronchopulmonary Aspergillosis?